Legend Biotech Corp. (LEGN)
28.12
+1.18
(+4.38%)
USD |
NASDAQ |
May 20, 16:00
27.66
-0.46
(-1.64%)
After-Hours: 07:01
Legend Biotech Shareholders Equity (Quarterly) : 967.73M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Imunon, Inc. | 3.360M |
| Capricor Therapeutics, Inc. | 278.70M |
| Viking Therapeutics, Inc. | 501.92M |
| Protagonist Therapeutics, Inc. | 655.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.597B |
| Total Liabilities (Quarterly) | 629.02M |
| Debt to Equity Ratio | 0.4023 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -0.23% |